藻油EPA

Search documents
金达威(002626) - 002626金达威投资者关系管理信息20250717
2025-07-18 00:30
Group 1: Company Overview - The company primarily engages in the research, production, and sales of nutritional health foods (including raw materials and finished products) and feed additives [2][3] - The production of health food raw materials and feed additives mainly occurs domestically, with a high export ratio; finished health food products are primarily produced and sold overseas, showing significant growth through cross-border e-commerce [3] Group 2: Product Development and Market Position - The company utilizes synthetic biology as a foundational technology for large-scale production of various raw materials, including Coenzyme Q10, NMN, NADH, Vitamin K2, and others [3] - Coenzyme Q10 holds the largest global market share, demonstrating notable cost and scale advantages [3] - The company aims to reduce production costs for products like astaxanthin, DHA, and EPA to enhance market competitiveness [3] Group 3: Brand and Sales Strategy - The company owns two major health food brands, Doctor's Best and Zipfizz, with production capabilities for capsules, tablets, and powders [3][4] - Doctor's Best is a well-known health brand in North America, showing steady growth, while Zipfizz maintains stable performance with new products developed for the U.S. market [4] - The marketing strategy for domestic health food business focuses on market insights, product strategy, resource integration, and data-driven upgrades to create market-leading products [4] Group 4: Financial Performance - The company's performance growth in the first half of 2025 is primarily attributed to increased sales of Coenzyme Q10, vitamins, and domestic health products [3]
金达威(002626) - 002626金达威投资者关系管理信息20250522
2025-05-22 08:42
编号:20250522 证券代码:002626 证券简称:金达威 20250522 投资者关系活动记录表 | | ☑特定对象调研 □分析师会议 | | --- | --- | | 投资者关系活动 | □媒体采访 □业绩说明会 | | 类别 | □新闻发布会 □路演活动 | | | □现场参观 | | | □其他 (请文字说明其他活动内容) | | 参与单位名称及 人员姓名 | | | | 浙商证券(杨骥) 银华基金(李爽) | | | 博时基金(钟天皓) | | | 方正富邦基金(庄英杰) | | | 永赢基金(潘俊汝) | | | 华泰证券资管(朱骏) | | | 天风证券(吴艾锜) | | | 深圳量度资本投资管理有限公司(罗涛) | | 时间 | 2025 年 5 月 22 日 | | 地点 | 公司会议室 | | 上市公司接待人 员姓名 | 董事会办公室 洪彦 林洁(证代) 张燕婷 | | | 调研主要围绕行业发展及公司各板块业务经营情况进行 交流,主要内容如下: | | 投资者关系活动 | 1. 公司目前的经营情况如何? | | 主要内容介绍 | 公司已顺利完成辅酶 Q10 原料生产线 1.5 倍扩 ...